PF-03446962, a fully-human monoclonal antibody against transforming growth-factor β (TGFβ) receptor ALK1, in pre-treated patients with urothelial cancer: an open label, single-group, phase 2 trial

Andrea Necchi, Filippo de Braud, Luigi Mariani et al.|Investigational New Drugs|2014

Cited by 54